The American HospitalAssociation disputed UHG's findings, saying that drug manufacturersthemselves are the main culprit in rising costs.

At a time when drug costs are a top concern for employers,UnitedHealth Group (UHG) has released a report finding thatspecialty drugs are a key driver of health care costs. The UHG study suggests that hospital delivery ofthese drugs contribute to the problem; the report claims that $4billion could be saved if such drugs were administered outside ofhospital settings.

However, the American Hospital Association (AHA) has pushed backhard, questioning the methodology of the UHG study and noting thatsome specialty drugs can only be administered at a hospital.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.